Korean J Ophthalmol.  2017 Aug;31(4):283-289. 10.3341/kjo.2017.0036.

Endophthalmitis

• Sheu SJ

• KMID: 2385576
• DOI: http://doi.org/10.3341/kjo.2017.0036

Abstract

Endophthalmitis is a rare but severe form of ocular inflammation due to infection of the intraocular cavity that can lead to irreversible visual loss if not treated properly and timely. It can be classified as exogenous or endogenous based on the transmission route of the infectious source. Exogenous endophthalmitis occurs when infecting organisms gain entry into the eye via direct inoculation, while endogenous endophthalmitis occurs when infectious agents hematogenously spread into the eye from a distant focus of infection. The diagnosis of endophthalmitis depends mostly on the clinical findings on ophthalmological examination. Delayed diagnosis of endogenous endophthalmitis can lead to not only visual loss, but also increased risk of mortality. Since ocular and systemic symptoms of endophthalmitis are usually non-specific, early diagnosis relies on the alertness of clinicians. Early diagnosis and proper treatment are keys to saving the eye. Following advances in vitreoretinal pharmacotherapy and surgical technology, early surgical intervention is the current trend in the management of endophthalmitis.

Keyword

Endogenous; Endophthalmitis; Exogenous

MeSH Terms

Delayed Diagnosis
Diagnosis
Drug Therapy
Early Diagnosis
Endophthalmitis*
Inflammation
Mortality

Figure

• 

  Fig. 1 (A) A 70-year-old female with diabetes developed endogenous endophthalmitis secondary to Klebsiella pneumoniae (KP) liver abscess. Clinical presentation included typical papillary hypopyon. (B) A 75-year-old diabetic male visited an ophthalmologist before the diagnosis of KP liver abscess. Clinical examination revealed severe panophthalmitis without history of ocular trauma or surgery. The eye was lost despite treatment with systemic and intravitreal antibiotics. (C) A 63-year-old male with hypertension and history of endocarditis and liver abscess treated elsewhere 3 months prior. Ocular examination showed hypopyon, lens opacity, and vitreous opacity. Inf lammation resolved after combined pars plana vitrectomy, extracapsular cataract extraction, and administration of intravitreal antibiotics. (D) A 45-year-old male with poorly controlled diabetes developed bilateral endophthalmitis secondary to KP liver abscess. Endophthalmitis resolved after systemic antibiotics and one treatment with intravitreal ceftazidime.

• 

  Fig. 2 (A) A case of severe exogenous fungal endophthalmitis secondary to eyeball rupture post repair. (B) A typical case of acute postoperative endophthalmitis after phacoemulsification. (C) A case of chronic bleb-related endophthalmitis.

Reference

1. Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina. 2007; 27:662–680.

2. Chee SP, Jap A. Endogenous endophthalmitis. Curr Opin Ophthalmol. 2001; 12:464–470.

3. Shrader SK, Band JD, Lauter CB, Murphy P. The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis. 1990; 162:115–120.

4. Krause L, Bechrakis NE, Heimann H, et al. Incidence and outcome of endophthalmitis over a 13-year period. Can J Ophthalmol. 2009; 44:88–94.

5. Ramakrishnan R, Bharathi MJ, Shivkumar C, et al. Microbiological profile of culture-proven cases of exogenous and endogenous endophthalmitis: a 10-year retrospective study. Eye (Lond). 2009; 23:945–956.

6. Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013; 19:227–234.

7. Lee S, Um T, Joe SG, et al. Changes in the clinical features and prognostic factors of endogenous endophthalmitis: fifteen years of clinical experience in Korea. Retina. 2012; 32:977–984.

8. Connell PP, O’Neill EC, Fabinyi D, et al. Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye (Lond). 2011; 25:66–72.

9. Wong JS, Chan TK, Lee HM, Chee SP. Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology. 2000; 107:1483–1491.

10. Karama EM, Willermain F, Janssens X, et al. Endogenous endophthalmitis complicating Klebsiella pneumoniae liver abscess in Europe: case report. Int Ophthalmol. 2008; 28:111–113.

11. Kashani AH, Eliott D. The emergence of Klebsiella pneumoniae endogenous endophthalmitis in the USA: basic and clinical advances. J Ophthalmic Inflamm Infect. 2013; 3:28.

12. Odouard C, Ong D, Shah PR, et al. Rising trends of endogenous Klebsiella pneumoniae endophthalmitis in Australia. Clin Exp Ophthalmol. 2017; 45:135–142.

13. Chen SC, Lee YY, Chen YH, et al. Klebsiella pneumoniae infection leads to a poor visual outcome in endogenous endophthalmitis: a 12-year experience in Southern Taiwan. Ocul Immunol Inflamm. 2016; 07. 20. 1–8. DOI: 10.1080/09273948.2016.1193616.

14. Park IH, Jun CH, Wi JW, et al. Prevalence of and risk factors for endogenous endophthalmitis in patients with pyogenic liver abscesses. Korean J Intern Med. 2015; 30:453–459.

15. Sheu SJ, Kung YH, Wu TT, et al. Risk factors for endogenous endophthalmitis secondary to klebsiella pneumoniae liver abscess: 20-year experience in Southern Taiwan. Retina. 2011; 31:2026–2031.

16. Lim HW, Shin JW, Cho HY, et al. Endogenous endophthalmitis in the Korean population: a six-year retrospective study. Retina. 2014; 34:592–602.

17. Jackson TL, Paraskevopoulos T, Georgalas I. Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol. 2014; 59:627–635.

18. Umazume K, Suzuki J, Usui Y, et al. Possible relation between lack of posterior vitreous detachment and severe endogenous endophthalmitis. J Ophthalmol. 2016; 2016:8561379.

19. Dozier CC, Tarantola RM, Jiramongkolchai K, Donahue SP. Fungal eye disease at a tertiary care center: the utility of routine inpatient consultation. Ophthalmology. 2011; 118:1671–1676.

20. Adam MK, Vahedi S, Nichols MM, et al. Inpatient ophthalmology consultation for fungemia: prevalence of ocular involvement and necessity of funduscopic screening. Am J Ophthalmol. 2015; 160:1078–1083.e2.

21. Paulus YM, Cheng S, Karth PA, Leng T. Prospective trial of endogenous fungal endophthalmitis and chorioretinitis rates, clinical course, and outcomes in patients with fungemia. Retina. 2016; 36:1357–1363.

22. Sadiq MA, Hassan M, Agarwal A, et al. Endogenous endophthalmitis: diagnosis, management, and prognosis. J Ophthalmic Inflamm Infect. 2015; 5:32.

23. Yoon YH, Lee SU, Sohn JH, Lee SE. Result of early vitrectomy for endogenous Klebsiella pneumoniae endophthalmitis. Retina. 2003; 23:366–370.

24. Mowat A, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med. 1971; 284:621–627.

25. Lin JC, Siu LK, Fung CP, et al. Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control. J Clin Endocrinol Metab. 2006; 91:3084–3087.

26. Coburn PS, Wiskur BJ, Christy E, Callegan MC. The diabetic ocular environment facilitates the development of endogenous bacterial endophthalmitis. Invest Ophthalmol Vis Sci. 2012; 53:7426–7431.

27. Sheu SJ, Chen YS, Lin HS, et al. A lack of ongoing diabetes is an important factor in preserving eyes from late or suboptimally treated endogenous endophthalmitis secondary to Klebsiella pneumoniae liver abscess. Taiwan J Ophthalmol. 2015; 5:23–27.

28. Hu CC, Ho JD, Lou HY, et al. A one-year follow-up study on the incidence and risk of endophthalmitis after pyogenic liver abscess. Ophthalmology. 2012; 119:2358–2363.

29. Sridhar J, Flynn HW Jr, Kuriyan AE, et al. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect. 2013; 3:60.

30. Tsai CC, Chen SJ, Chung YM, et al. Postpartum endogenous Candida endophthalmitis. J Formos Med Assoc. 2002; 101:432–436.

31. Lee JH, Kim JS, Park YH. Diagnosis and treatment of postpartum Candida endophthalmitis. J Obstet Gynaecol Res. 2012; 38:1220–1222.

32. Potasman I, Leibovitz Z, Sharf M. Candida sepsis in pregnancy and the postpartum period. Rev Infect Dis. 1991; 13:146–149.

33. Lamaris GA, Esmaeli B, Chamilos G, et al. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis. 2008; 27:343–347.

34. Vaziri K, Schwartz SG, Kishor K, Flynn HW Jr. Endophthalmitis: state of the art. Clin Ophthalmol. 2015; 9:95–108.

35. Lalwani GA, Flynn HW Jr, Scott IU, et al. Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005): clinical features, causative organisms, and visual acuity outcomes. Ophthalmology. 2008; 115:473–476.

36. Govetto A, Virgili G, Menchini F, et al. A systematic review of endophthalmitis after microincisional versus 20-gauge vitrectomy. Ophthalmology. 2013; 120:2286–2291.

37. Park JC, Ramasamy B, Shaw S, et al. A prospective and nationwide study investigating endophthalmitis following pars plana vitrectomy: clinical presentation, microbiology, management and outcome. Br J Ophthalmol. 2014; 98:1080–1086.

38. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina. 2004; 24:676–698.

39. Moshfeghi AA, Charalel RA, Hernandez-Boussard T, et al. Declining incidence of neonatal endophthalmitis in the United States. Am J Ophthalmol. 2011; 151:59–65.e1.

40. Freiberg FJ, Brynskov T, Munk MR, et al. Low endophthalmitis rates after intravitreal anti-vascular endothelial growth factor injections in an operation room: a retrospective multicenter study. Retina. 2017; 01. 17. DOI: 10.1097/IAE.0000000000001488.

41. Benoist d'Azy C, Pereira B, Naughton G, et al. Antibioprophylaxis in prevention of endophthalmitis in intravitreal injection: a systematic review and meta-analysis. PLoS One. 2016; 11:e0156431.

42. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996; 122:830–846.

43. Xu K, Chin EK, Almeida DR. Five-port combined limbal and pars plana vitrectomy for infectious endophthalmitis. Case Rep Ophthalmol. 2016; 7:289–291.

44. Ahmed Y, Schimel AM, Pathengay A, et al. Endophthalmitis following open-globe injuries. Eye (Lond). 2012; 26:212–217.

45. Wykoff CC, Flynn HW Jr, Miller D, et al. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology. 2008; 115:1501–1507.

46. Pflugfelder SC, Flynn HW Jr, Zwickey TA, et al. Exogenous fungal endophthalmitis. Ophthalmology. 1988; 95:19–30.

47. Kim DY, Moon HI, Joe SG, et al. Recent clinical manifestation and prognosis of fungal endophthalmitis: a 7-year experience at a tertiary referral center in Korea. J Korean Med Sci. 2015; 30:960–964.

48. Mikosz CA, Smith RM, Kim M, et al. Fungal endophthalmitis associated with compounded products. Emerg Infect Dis. 2014; 20:248–256.